You pick apart information and put them in different post to confuse. Very well, lets play your game.
> Cash outflows in the two reported quarters since that A$75m raising amounted to US$43m (around A$68m), so most of the $75m
MSB had cash of US$ 34.5 million by of by the end of Sept 2019. They raised additional cash of US$50,6 million (AUD$75 million) to "principally" build inventory and a targeted US sales force. They also said that the fund will be used to finish phase 3 heart and lower back pain. This leaves MSB with US$ 81.3 million cash by 31 Dec 2019. Last quarterly reported US$ 60 million by 31 March 2020. By this time, heart and lower back pain are all completed. Note that half of operating cash outflow are for R&D. This component should significantly reduce in the future. The future look bright.
You pick apart information and put them in different post to...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.030(1.90%) |
Mkt cap ! $1.832B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.65 | $1.59 | $7.014M | 4.343M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 342 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 54534 | 8 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |